SomnoMed (SomnoMed) Insider Ownership : 0.00 % (As of Jun. 02, 2024)

View and export this data going back to 2016. Start your Free Trial

What is SomnoMed Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, SomnoMed's insider ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, SomnoMed's Institutional Ownership is 8.68%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, SomnoMed's Float Percentage Of Total Shares Outstanding is 0.00%.

SomnoMed Insider Ownership Historical Data

The historical data trend for SomnoMed's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SomnoMed Insider Ownership Chart

SomnoMed Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Insider Ownership

Get a 7-Day Free Trial

SomnoMed Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Insider Ownership	Get a 7-Day Free Trial															-	-	-	-	-

SomnoMed Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

SomnoMed (SomnoMed) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SomnoMed Ltd (OTCPK:SOMNF) » Definitions » Insider Ownership

Comparable Companies

Traded in Other Exchanges

RJV:Germany SOM:Australia

Address

20 Clarke Street, Level 3, Crows Nest, Sydney, NSW, AUS, 2065

Website

https://www.somnomed.com/au

SomnoMed Ltd produces and sells oral treatment of sleep-related disorder devices. It manufactures and designs premium oral appliances for the treatment of sleep-disordered breathing relieving conditions. Its products include SomnoDent, Som Tabs, Som Morning Repositioner and others. Its geographical segments include North America, Europe, and Asia-Pacific. Business operations consist of the production and sale of products treating sleep-disordered breathing, which is the only reportable segment. Substantial revenue is realized from the European region.

SomnoMed (SomnoMed) Headlines

From GuruFocus

SomnoMed posts record Q4 and delivers on FY22 revenue guidance

By PRNewswire PRNewswire • 07-26-2022

SomnoMed's North America Q1 revenue growth leads the way

By PRNewswire PRNewswire • 10-28-2022